Paul Castillo Caro

Rational tuning of CAR T cells against osteosarcoma for enhanced activity and reduced toxicity

Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic

Unlocking CAR T cells Activity Against Metastatic Osteosarcoma Using Systemic RNA Vaccination

Enhancing CD70 CAR T cell Homing to Acute Myeloid Leukemic Sites Leveraging Chemokine Signaling

Reprogramming Glioblastoma: Harnessing Adeno-Associated Virus for Immune Gene Therapy

214 CTOA: Castillo Caro

Pediatric Oncology Student Training (POST) Program

Clinical Outcomes of Pediatric MDS: A Retrospective Review by the North American Pediatric Aplastic Anemia Consortium (NAPAAC)

CHAMP1ON - Combinatorial Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade Phase 1 "Window of Opportunity" Trial for RecurreNt Pediatric High-Grade Glioma

Unlocking Chimeric Antigen Receptor T cell Activity Against Acute Myeloid Leukemia Using RNA-nanoparticle Vaccination

Utilization of Alpha/Beta T Cell and B Cell Depletion in Allogeneic Stem Cell Transplantation in Malignant Diseases

Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)

Overcoming Resistance of Acute Myeloid Leukemia by Enhancing CAR T Cell Activity Using Systemic Vaccination.

Leveraging CD70 CXCR2-modified CAR T-cells for treating AML

Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Unlocking CAR T cell efficacy against osteosarcoma using adjuvant RNA vaccine

Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant

Engineered Donor Graft for Pediatric Hematopoietic Cell Transplant (HCT) Recipients with Hematologic Malignancies (HM)- Florida Pediatric Bone Marrow Transplant and Cell Therapy Consortium (FPBCC) First Prospective Multicenter Trial

Targeting Primary CNS B cell Lymphoma Unique Antigens with Novel Immunotherapy

Enhancing T cell adoptive therapy against T cell acute lymphoblastic leukemia

A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia

Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection

Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection

214 Fund Retrospective Study of Pediatric Aplastic Anemia

Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric and Young Adult Leukemia Post Allogeneic Stem Cell Transplantation